FYERS
Home
/
Stocks
/
Results
/
Laurus Labs Results

Laurus Labs Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
14%7%4%23%
21%-2%4%151%
-27%74%123%
18%16%10%18%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
—————————————
₹108 Cr₹108 Cr₹108 Cr₹108 Cr₹107 Cr₹107 Cr₹107 Cr₹106 Cr₹106 Cr₹106 Cr₹82 Cr₹82 Cr₹78 Cr
₹25 Cr₹26 Cr₹21 Cr₹12 Cr₹9 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹3 Cr₹3 Cr₹3 Cr
₹5167 Cr₹4339 Cr₹3982 Cr₹3918 Cr₹3235 Cr₹2485 Cr₹1658 Cr₹1447 Cr₹1371 Cr₹1219 Cr₹771 Cr₹637 Cr₹277 Cr
₹5167 Cr₹4339 Cr₹3982 Cr₹3918 Cr₹3235 Cr₹2485 Cr₹1658 Cr₹1447 Cr₹1371 Cr₹1219 Cr₹771 Cr₹637 Cr₹277 Cr
₹5300 Cr₹4473 Cr₹4111 Cr₹4038 Cr₹3351 Cr₹2598 Cr₹1770 Cr₹1558 Cr₹1483 Cr₹1330 Cr₹857 Cr₹722 Cr₹358 Cr
₹131 Cr₹130 Cr₹5 Cr₹11 Cr₹8 Cr₹3 Cr₹0₹0₹0₹0₹0₹0₹0
₹611 Cr₹646 Cr₹798 Cr₹761 Cr₹596 Cr₹429 Cr₹165 Cr₹259 Cr₹142 Cr₹125 Cr₹354 Cr₹304 Cr₹188 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹106 Cr₹0₹0
₹29 Cr₹32 Cr₹57 Cr₹82 Cr₹69 Cr₹19 Cr-₹74 Cr-₹53 Cr-₹53 Cr-₹70 Cr-₹55 Cr₹10 Cr₹12 Cr
₹672 Cr₹410 Cr₹210 Cr₹254 Cr₹190 Cr₹181 Cr₹77 Cr₹60 Cr₹65 Cr₹63 Cr₹16 Cr₹45 Cr₹0
₹132 Cr₹106 Cr₹93 Cr₹81 Cr₹73 Cr₹63 Cr₹46 Cr₹30 Cr₹21 Cr₹15 Cr₹7 Cr₹5 Cr₹4 Cr
₹1444 Cr₹1193 Cr₹1159 Cr₹1179 Cr₹928 Cr₹693 Cr₹214 Cr₹295 Cr₹174 Cr₹132 Cr₹428 Cr₹364 Cr₹204 Cr
—————————————
₹1252 Cr₹958 Cr₹1051 Cr₹711 Cr₹876 Cr₹1179 Cr₹616 Cr₹488 Cr₹312 Cr₹263 Cr₹248 Cr₹231 Cr₹227 Cr
₹799 Cr₹780 Cr₹611 Cr₹641 Cr₹840 Cr₹367 Cr₹261 Cr₹244 Cr₹231 Cr₹199 Cr₹141 Cr₹133 Cr₹164 Cr
₹1493 Cr₹1715 Cr₹1389 Cr₹996 Cr₹911 Cr₹886 Cr₹791 Cr₹684 Cr₹759 Cr₹644 Cr₹481 Cr₹432 Cr₹312 Cr
₹92 Cr₹87 Cr₹61 Cr₹85 Cr₹54 Cr₹25 Cr₹25 Cr₹7 Cr₹5 Cr₹14 Cr₹14 Cr₹7 Cr₹7 Cr
₹3635 Cr₹3540 Cr₹3112 Cr₹2432 Cr₹2681 Cr₹2457 Cr₹1692 Cr₹1424 Cr₹1307 Cr₹1121 Cr₹884 Cr₹802 Cr₹711 Cr
₹10511 Cr₹9336 Cr₹8387 Cr₹7660 Cr₹6968 Cr₹5751 Cr₹3676 Cr₹3278 Cr₹2964 Cr₹2584 Cr₹2169 Cr₹1888 Cr₹1273 Cr
₹421 Cr₹426 Cr₹154 Cr₹152 Cr₹119 Cr₹122 Cr₹104 Cr₹103 Cr₹92 Cr₹48 Cr₹56 Cr₹185 Cr₹169 Cr
₹2397 Cr₹2693 Cr₹2507 Cr₹1972 Cr₹1732 Cr₹1453 Cr₹1057 Cr₹1036 Cr₹980 Cr₹842 Cr₹1028 Cr₹821 Cr₹543 Cr
—————————————
₹6970 Cr₹6284 Cr₹5652 Cr₹4795 Cr₹3750 Cr₹3028 Cr₹2388 Cr₹2105 Cr₹1794 Cr₹1419 Cr₹1106 Cr₹986 Cr₹623 Cr
₹2600 Cr₹2161 Cr₹1762 Cr₹1386 Cr₹1098 Cr₹857 Cr₹661 Cr₹476 Cr₹313 Cr₹189 Cr₹85 Cr₹185 Cr₹124 Cr
₹4371 Cr₹4123 Cr₹3890 Cr₹3409 Cr₹2652 Cr₹2171 Cr₹1726 Cr₹1629 Cr₹1481 Cr₹1230 Cr₹1021 Cr₹801 Cr₹499 Cr
₹773 Cr₹458 Cr₹423 Cr₹551 Cr₹813 Cr₹362 Cr₹67 Cr₹110 Cr₹163 Cr₹143 Cr₹70 Cr₹110 Cr₹116 Cr
₹309 Cr₹233 Cr₹124 Cr₹50 Cr₹31 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹7 Cr₹7 Cr₹0
₹309 Cr₹233 Cr₹124 Cr₹50 Cr₹31 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹7 Cr₹7 Cr₹0
₹201 Cr₹163 Cr₹84 Cr₹161 Cr₹84 Cr₹109 Cr₹41 Cr₹26 Cr₹29 Cr₹26 Cr₹29 Cr₹94 Cr₹69 Cr
₹28 Cr₹25 Cr₹32 Cr₹29 Cr₹43 Cr₹31 Cr₹27 Cr₹47 Cr₹39 Cr₹41 Cr₹39 Cr₹12 Cr₹13 Cr
₹5682 Cr₹5003 Cr₹4552 Cr₹4199 Cr₹3623 Cr₹2676 Cr₹1864 Cr₹1815 Cr₹1716 Cr₹1444 Cr₹1166 Cr₹1024 Cr₹697 Cr
—————————————
₹2342 Cr₹1937 Cr₹1845 Cr₹1685 Cr₹1760 Cr₹1575 Cr₹905 Cr₹682 Cr₹585 Cr₹509 Cr₹487 Cr₹475 Cr₹328 Cr
₹2155 Cr₹2007 Cr₹1663 Cr₹1580 Cr₹1354 Cr₹1306 Cr₹791 Cr₹710 Cr₹571 Cr₹568 Cr₹445 Cr₹285 Cr₹195 Cr
₹114 Cr₹144 Cr₹142 Cr₹48 Cr₹76 Cr₹48 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹29 Cr₹59 Cr₹23 Cr
₹34 Cr₹37 Cr₹38 Cr₹39 Cr₹20 Cr₹57 Cr₹52 Cr₹33 Cr₹31 Cr₹34 Cr₹18 Cr₹20 Cr₹9 Cr
₹184 Cr₹207 Cr₹147 Cr₹109 Cr₹134 Cr₹88 Cr₹62 Cr₹35 Cr₹59 Cr₹25 Cr₹24 Cr₹23 Cr₹20 Cr
₹4829 Cr₹4332 Cr₹3835 Cr₹3462 Cr₹3345 Cr₹3075 Cr₹1812 Cr₹1463 Cr₹1248 Cr₹1140 Cr₹1003 Cr₹862 Cr₹575 Cr
₹1194 Cr₹793 Cr₹723 Cr₹1029 Cr₹664 Cr₹618 Cr₹120 Cr₹39 Cr-₹59 Cr₹19 Cr₹119 Cr₹60 Cr-₹136 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹2 Cr
₹10511 Cr₹9336 Cr₹8387 Cr₹7660 Cr₹6968 Cr₹5751 Cr₹3676 Cr₹3278 Cr₹2964 Cr₹2584 Cr₹2169 Cr₹1888 Cr₹1273 Cr
₹98₹82₹76₹75₹62₹48₹165₹146₹139₹125₹499₹420₹189
₹98₹82₹76₹75₹62₹48₹33₹29₹28₹25₹25₹21₹9

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
₹1182 Cr₹484 Cr₹236 Cr₹1109 Cr₹1084 Cr₹1301 Cr₹294 Cr₹120 Cr₹237 Cr₹235 Cr₹169 Cr₹67 Cr₹121 Cr
₹710 Cr₹630 Cr₹563 Cr₹486 Cr₹351 Cr₹254 Cr₹293 Cr₹248 Cr₹216 Cr₹199 Cr₹201 Cr₹136 Cr₹83 Cr
₹25 Cr-₹375 Cr-₹29 Cr-₹315 Cr-₹342 Cr-₹594 Cr-₹200 Cr-₹44 Cr-₹49 Cr-₹52 Cr-₹154 Cr-₹251 Cr-₹59 Cr
₹1917 Cr₹739 Cr₹770 Cr₹1279 Cr₹1093 Cr₹962 Cr₹387 Cr₹323 Cr₹404 Cr₹382 Cr₹215 Cr-₹48 Cr₹145 Cr
₹1624 Cr₹602 Cr₹666 Cr₹994 Cr₹911 Cr₹733 Cr₹347 Cr₹298 Cr₹342 Cr₹332 Cr₹182 Cr-₹65 Cr₹121 Cr
-₹1089 Cr-₹682 Cr-₹822 Cr-₹996 Cr-₹914 Cr-₹941 Cr-₹221 Cr-₹253 Cr-₹384 Cr-₹289 Cr-₹312 Cr-₹397 Cr-₹312 Cr
-₹525 Cr₹39 Cr₹250 Cr-₹27 Cr₹30 Cr₹255 Cr-₹128 Cr-₹45 Cr₹42 Cr-₹54 Cr₹103 Cr₹486 Cr₹203 Cr
₹10 Cr-₹41 Cr₹93 Cr-₹29 Cr₹27 Cr₹47 Cr-₹1 Cr₹2 L₹59 L-₹10 Cr-₹27 Cr₹24 Cr₹12 Cr
₹100 Cr₹139 Cr₹46 Cr₹75 Cr₹48 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹13 Cr₹40 Cr₹15 Cr₹3 Cr
₹3 Cr₹1 Cr₹17 L-₹88 L-₹13 L₹6 L₹9 L-₹5 L-₹40,000-₹9 L₹19 L₹0₹0
₹113 Cr₹100 Cr₹139 Cr₹46 Cr₹75 Cr₹48 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹13 Cr₹40 Cr₹15 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)2,021.10
Volume (₹)13.88 L
High (₹)2,055.30
Upper Circuit2,092.70
Low (₹)2,020.00
Lower Circuit1,970.90
Prev Close2,034.00
52W High (₹)2,055.30
Price2,026.20
52W Low (₹)823.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)109943.00 Cr
Div. Yield (%)0.10
PE Ratio100.55
Debt to Equity0.45
Price to Book10.15
Book Value97.71
EPS (TTM)20.24
Face Value2.00
ROE (%)18.31

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr

Laurus Labs Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹647.45Cr; with other income of ₹9.18Cr, profit before interest and tax came to ₹523.58Cr. Interest expense was ₹42.22Cr; PBT before exceptional items stood at ₹481.36Cr. Cost mix (full year): raw materials ₹2871.96Cr; employee cost ₹815.39Cr; depreciation ₹123.87Cr; other expenses ₹1388.04Cr. Basis: consolidated annual results.

Laurus Labs Ltd Quaterly Results Key Takeaways

Laurus Labs Ltd reported ₹2026.31Cr total income from operations in Jun 2026, softer than ₹1811.57Cr in Mar 2026 but higher than ₹1569.57Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹647.45Cr; with other income of ₹9.18Cr, profit before interest and tax came to ₹523.58Cr. Interest expense was ₹42.22Cr, taking profit before tax to ₹481.36Cr. After tax of ₹119.37Cr, profit after tax stood at ₹361.99Cr (vs ₹281.91Cr in Mar 2026 and ₹161.08Cr in Jun 2025).